Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms

J B Dressman1, G L Amidon, C Reppas

  • 1Johann Wolfgang Goethe-Universität, Institut für Pharmazeutische Technologie, Frankfurt am Main, Germany.

Pharmaceutical Research
|March 6, 1998
PubMed
Summary

Developing better dissolution tests requires understanding gastrointestinal conditions. This research clarifies when dissolution testing predicts in vivo performance and provides physiological data for improved in vitro test design.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the reach and impact of a UK campaign highlighting obesity as a cause of cancer among the general public and Members of Parliament.

Public health·2023
Same author

Drug Permeability - Best Practices for Biopharmaceutics Classification System (BCS)-Based Biowaivers: A workshop Summary Report.

Journal of pharmaceutical sciences·2023
Same author

UNGAP best practice for improving solubility data quality of orally administered drugs.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences·2021
Same author

Mechanistic analysis and experimental verification of bicarbonate-controlled enteric coat dissolution: Potential in vivo implications.

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V·2019
Same author

Mechanistic Oral Absorption Modeling and Simulation for Formulation Development and Bioequivalence Evaluation: Report of an FDA Public Workshop.

CPT: pharmacometrics & systems pharmacology·2017
Same author

In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.

Molecular pharmaceutics·2017

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery
  • Biopharmaceutics

Background:

  • Dissolution testing is crucial for pharmaceutical development, quality control, and bioequivalence.
  • Regulatory changes, like the Biopharmaceutics Classification Scheme, emphasize dissolution's role in post-approval modifications and potential clinical study substitutions.
  • There's a growing need for dissolution tests that accurately predict in vivo drug product performance.

Purpose of the Study:

  • To elucidate the conditions under which dissolution testing can prognosticate in vivo drug product performance.
  • To present physiological data of the gastrointestinal tract relevant for designing improved in vitro dissolution tests.
  • To offer insights into in vitro dissolution media composition, hydrodynamics, and test duration.

Main Methods:

Keywords:
Non-programmatic

Related Experiment Videos

  • Review and synthesis of existing literature on dissolution testing and gastrointestinal physiology.
  • Analysis of physiological parameters including fluid composition, volume, flow rates, and mixing patterns in the GI tract.
  • Discussion of implications for designing more predictive in vitro dissolution tests.

Main Results:

  • Dissolution tests can be prognostic for in vivo performance when in vitro conditions mimic the physiological environment.
  • Key physiological data for GI tract fluid dynamics and composition are presented.
  • Recommendations are made for optimizing in vitro dissolution media and test parameters.

Conclusions:

  • Accurate prediction of in vivo drug performance via dissolution testing hinges on replicating gastrointestinal conditions in vitro.
  • Understanding GI tract physiology is essential for developing more effective and regulatory-accepted dissolution tests.
  • Further refinement of in vitro dissolution methodologies can reduce reliance on clinical studies for certain pharmaceutical assessments.